Standard BioTools Inc. (LAB)

Bally's Revenue

Standard BioTools had revenue of $21.76M in the quarter ending June 30, 2025, a decrease of -41.51%. This brings the company's revenue in the last twelve months to $172.27M, up 26.39% year-over-year. In the year 2024, Standard BioTools had annual revenue of $174.43M with 64.03% growth.

• Revenue (ttm): $172.27M
• Revenue Growth: +26.39%
• P/S Ratio: 2.80
• Revenue / Employee: $210,600
• Employees: 818
• Market Cap: 499.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	174.43M	68.09M	64.03%
Dec 31, 2023	106.34M	8.39M	8.57%
Dec 31, 2022	97.95M	-32.63M	-24.99%
Dec 31, 2021	130.58M	-7.56M	-5.47%
Dec 31, 2020	138.14M	20.90M	17.83%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.